BioSyent (CVE:RX) Sets New 1-Year High at $9.32
Shares of BioSyent Inc. (CVE:RX – Get Free Report) reached a new 52-week high during mid-day trading on Wednesday . The company traded as high as C$9.32 and last traded at C$9.32, with a volume of 11950 shares changing hands. The stock had previously closed at C$9.25. BioSyent Stock Performance The stock has a market […]
More Stories
‘Complete Obliteration’: DeSantis Says Hurricane Helene Damage Worse Than Idalia
By T. J. Muscaro TAMPA—Florida’s Gov. Ron DeSantis said Hurricane Helene’s “monumental storm surge” caused far greater damage than last...
US and Iraq Announce Changes to Military Footprint After Years-Long Joint Fight Against ISIS
By Chase Smith In a joint statement released on Sept. 27, the United States and Iraq announced plans for a...
Nestlé S.A. (OTCMKTS:NSRGY) Short Interest Up 152.5% in September
Nestlé S.A. (OTCMKTS:NSRGY – Get Free Report) saw a significant growth in short interest in September. As of September 15th,...
Short Interest in BlackRock Capital Allocation Term Trust (NYSE:BCAT) Expands By 100.6%
BlackRock Capital Allocation Term Trust (NYSE:BCAT – Get Free Report) was the recipient of a large growth in short interest...
Cenovus Energy Inc. (NYSE:CVE) Sees Significant Growth in Short Interest
Cenovus Energy Inc. (NYSE:CVE – Get Free Report) (TSE:CVE) was the target of a significant increase in short interest in...
Trees Co. (OTCMKTS:CANN) Short Interest Up 108.3% in September
Trees Co. (OTCMKTS:CANN – Get Free Report) saw a large increase in short interest during the month of September. As...